HuB14-VA-PL2202

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameHuB14-VA-PL2202

Drug Alias NameHuB14-VA-PL2202

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker

Mechanisms of ActionAnti-Neutral amino acid transporter B(0)DNA topoisomerase I inhibitors

TargetsNeutral amino acid transporter B(0)DNA topoisomerase I

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAdc Therapeutics Sa

China Registration ClassN/A

Develop Information

Active CompaniesAdc Therapeutics Sa

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A